Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines-Reference-Cited by-同舟云学术

Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines

Published:2006-05 Issue:20 Volume:24 Page:4328-4332
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Orr Nadav,Klement Eyal,Gillis David,Sela Tamar,Kayouf Raid,Derazne Estela,Grotto Itamar,Balicer Ran,Huerta Michael,Aviram Lisa,Ambar Ruhama,Epstein Yoram,Heled Yuval,Cohen Dani

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference16 articles.

1. A randomised comparison of two inactivated hepatitis A vaccines, Avaxim and Vaqta, given as a booster to subjects primed with Avaxim;Clarke;Vaccine,2001

2. Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix;Connor;Clin Infect Dis,2001

3. Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL. U) as a booster following primary immunization with Havrix (1440 EL. U) against hepatitis.;Zuckerman;Am J Travel Med,1998

4. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines;Van Herck;J Med Virol,2000

5. Hepatitis A vaccine: evidence of immune memory 12 years after the primary course;Van Herck;J Med Virol,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delaying the third dose of Japanese aluminum-free hepatitis A vaccine Aimmugen elicits effective immune responses against hepatitis A in adults;Vaccine;2023-07

2. Physical Activity and COVID-19 Vaccines;Physical Activity and Pandemics;2023

3. Using the power law model to predict the long-term persistence and duration of detectable hepatitis A antibody after receipt of hepatitis A vaccine (VAQTA™);Vaccine;2021-05

4. Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule;Vaccine;2020-02

5. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations;RMD Open;2019-09